Theator Named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups
"This is the fifth year CB Insights has recognized the most promising private artificial intelligence companies with the AI 100, and this is one of the most global groups we've ever seen. This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are proud that CB Insights has recognized Theator as one of the Most Innovative Artificial Intelligence Startups, as we define and lead the new category of Surgical Intelligence, leveraging AI and computer vision to introduce advanced video analytics into the world of surgery," said Dr. Tamir Wolf, CEO and Co-Founder of Theator. "A tremendous amount of data, and therefore knowledge, are lost every single day in operating rooms around the world, as intraoperative videos are not captured, stored, or analyzed. We are thrilled that CB Insights has chosen to recognize our mission of deploying technological excellence to provide surgeons and other stakeholders in the healthcare ecosystem with actionable value and ultimately eradicate variability and disparity in surgical care."
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights' algorithm, measures the overall health and growth potential of private companies to help predict a company's momentum.
Theator's advaned AI platform transforms unstructured surgical video data into actionable insights in the form of steps, events, milestones, and decisions, leveraging the ever-increasing amount of previously untapped surgical data from the operating room. Surgeons can now efficiently pursue lifelong learning by using the platform to enhance their overall performance. This is achieved by analyzing curated footage of their own procedures and those of others, as well as gaining access to real-world peer insights from a quality-assured dataset. Theator has been named as one of CB Insights' Most Innovative AI Startups following the announcement earlier this year of a $15.5M Series A funding round led by Insight Partners. Over the past year, Theator has also announced partnerships with several medical institutions, including Tel Aviv Sourasky Medical Center (Ichilov Hospital), McGill University Health Centre, and leading surgical societies such as the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
Quick facts on the 2021 AI 100:
About CB Insights
Theator Media Contact:
Sales and Marketing For Independent Provider of Cloud Voice Services
Smarter Strategies for IoT Deployment
Keynote Presentation by Zoom